Advertisement
Advertisement
NAGE
Niagen Bioscience, Inc. Common Stock
5.93
USD+0.26
+4.60%
Apr 11, 15:59 UTC -4
Closed
After-Market
5.92
-0.01
-0.10%
Niagen Bioscience, Inc. Common Stock Profile
Info & Links
CEO
Robert Fried
Headquarters
Los Angeles, CA 90024, UNITED STATES
Industry
Sector
Website
Auditor
Crowe LLP
Share holders
36
Employees
104
Niagen Bioscience, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
460.67M
Enterprise Value
416.02M
Enterprise Value/EBITDA(ttm)
48.71
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
--
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
61.73%
Operating Margin(ttm)
--
Profit Margin(ttm)
7.43%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
19.29%
Return on Assets(ttm)
--
Income Statement
Revenue(ttm)
99.60M
Revenue Per Share(ttm)
1.28
Gross Profit(ttm)
61.59M
EBITDA(ttm)3
8.54M
Net Income Available to Common(ttm)
8.55M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
--
52-Week Change
--
S&P 500 52-Week Change
4.68%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
77.75M
Dividend Yield
--
Float4
--
% Held by Insiders
--
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
44.66M
Total Cash Per Share(mrq)
0.57
Total Debt(mrq)
12.00K
Total Debt/Equity(mrq)
0.03%
Current Ratio(mrq)
3.57%
Quick Ratio(mrq)
--
Book Value Per Share(mrq)
0.60
Cash Flow
Operating Cash Flow Per Share(ytd)
0.15
Free Cash Flow(ytd)
11.97M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement